Patents by Inventor Yoshiharu Iwabuchi

Yoshiharu Iwabuchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240088184
    Abstract: There is provided a imaging device including: an N-type region formed for each pixel and configured to perform photoelectric conversion; an inter-pixel light-shielding wall penetrating a semiconductor substrate in a depth direction and formed between N-type regions configured to perform the photoelectric conversion, the N-type regions each being formed for each of pixels adjacent to each other; a P-type layer formed between the N-type region configured to perform the photoelectric conversion and the inter-pixel light-shielding wall; and a P-type region adjacent to the P-type layer and formed between the N-type region and an interface on a side of a light incident surface of the semiconductor substrate.
    Type: Application
    Filed: November 16, 2023
    Publication date: March 14, 2024
    Applicant: SONY SEMICONDUCTOR SOLUTIONS CORPORATION
    Inventors: Tetsuya UCHIDA, Ryoji SUZUKI, Hisahiro ANSAI, Yoichi Ueda, Shinichi YOSHIDA, Yukari TAKEYA, Tomoyuki HIRANO, Hiroyuki MORI, Hirotoshi NOMURA, Yoshiharu KUDOH, Masashi OHURA, Shin IWABUCHI
  • Patent number: 11912688
    Abstract: The present invention provides a compound represented by chemical formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: February 27, 2024
    Assignee: Tohoku University
    Inventors: Akira Sugawara, Atsushi Yokoyama, Susumu Suzuki, Yoshiharu Iwabuchi, Takayuki Doi
  • Patent number: 11608313
    Abstract: The present invention provides a pharmaceutical composition for treating or preventing a cognitive disease or disorder, comprising a compound represented by Formula (I), an enantiomer thereof a diastereomer thereof, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 2, 2018
    Date of Patent: March 21, 2023
    Assignee: Tohoku University
    Inventors: Shigeki Moriguchi, Kohji Fukunaga, Yoshiharu Iwabuchi
  • Publication number: 20220033386
    Abstract: The present invention provides a compound represented by chemical formula (I) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same.
    Type: Application
    Filed: February 14, 2020
    Publication date: February 3, 2022
    Applicant: TOHOKU UNIVERSITY
    Inventors: Akira SUGAWARA, Atsushi YOKOYAMA, Susumu SUZUKI, Yoshiharu IWABUCHI, Takayuki DOI
  • Publication number: 20200181066
    Abstract: The present invention provides a pharmaceutical composition for treating or preventing a cognitive disease or disorder, comprising a compound represented by Formula (I), an enantiomer thereof a diastereomer thereof, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 2, 2018
    Publication date: June 11, 2020
    Applicants: TOHOKU UNIVERSITY, Brain Innovation Co., Inc.
    Inventors: Shigeki MORIGUCHI, Koji FUKUNAGA, Yoshiharu IWABUCHI
  • Patent number: 10487045
    Abstract: The present invention provides a pharmaceutical composition for treating or preventing a cognitive disease or disorder, containing a compound represented by Formula (I), an enantiomer thereof, a diastereomer thereof, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: November 26, 2019
    Assignees: Tohoku University, Brain Innovation Co., Inc.
    Inventors: Shigeki Moriguchi, Koji Fukunaga, Yoshiharu Iwabuchi
  • Publication number: 20190055191
    Abstract: The present invention provides a pharmaceutical composition for treating or preventing a cognitive disease or disorder, containing a compound represented by Formula (I), an enantiomer thereof, a diastereomer thereof, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 26, 2017
    Publication date: February 21, 2019
    Applicant: TOHOKU UNIVERSITY
    Inventors: Shigeki MORIGUCHI, Koji FUKUNAGA, Yoshiharu IWABUCHI
  • Patent number: 9114390
    Abstract: An organocatalyst for oxidizing alcohols in which a primary alcohol is selectively oxidized in a polyol substrate having a plurality of alcohols under environmentally-friendly conditions. The organic oxidation catalyst has an oxygen atom bonded to a nitrogen atom of an azanoradamantane skeleton and at least one alkyl group at positions 1 and 5. The oxidation catalyst has higher activity than TEMPO, which is an existing oxidation catalyst, in the selective oxidation reaction of primary alcohols, and better selectivity than AZADO and 1-Me-AZADO. This DMN-AZADO can be applied to the selective oxidation reaction of primary alcohols that contributes to shortening the synthesizing process for pharmaceuticals, pharmaceutical raw materials, agricultural chemicals, cosmetics, organic materials, and other such high value-added organic compounds.
    Type: Grant
    Filed: February 22, 2013
    Date of Patent: August 25, 2015
    Assignee: TOHOKU UNIVERSITY
    Inventors: Yoshiharu Iwabuchi, Masatoshi Shibuya, Ryusuke Doi
  • Publication number: 20150031887
    Abstract: An organocatalyst for oxidizing alcohols in which a primary alcohol is selectively oxidized in a polyol substrate having a plurality of alcohols under environmentally-friendly conditions. The organic oxidation catalyst has an oxygen atom bonded to a nitrogen atom of an azanoradamantane skeleton and at least one alkyl group at positions 1 and 5. The oxidation catalyst has higher activity than TEMPO, which is an existing oxidation catalyst, in the selective oxidation reaction of primary alcohols, and better selectivity than AZADO and 1-Me-AZADO. This DMN-AZADO can be applied to the selective oxidation reaction of primary alcohols that contributes to shortening the synthesizing process for pharmaceuticals, pharmaceutical raw materials, agricultural chemicals, cosmetics, organic materials, and other such high value-added organic compounds.
    Type: Application
    Filed: February 22, 2013
    Publication date: January 29, 2015
    Inventors: Yoshiharu Iwabuchi, Masatoshi Shibuya, Ryusuke Doi
  • Patent number: 8871981
    Abstract: A method for oxidizing an alcohol, wherein oxidation is performed in the presence of a compound represented by the following formula (I) and a bulk oxidant, which enables efficient oxidation of secondary alcohols as well as primary alcohols, and can attain high reaction efficiency even when air is used as a bulk oxidant.
    Type: Grant
    Filed: May 30, 2011
    Date of Patent: October 28, 2014
    Assignee: Tohoku University
    Inventors: Yoshiharu Iwabuchi, Masaki Hayashi
  • Patent number: 8669367
    Abstract: To provide a method whereby a 2-azaadamantane can easily be obtained in good yield. A method for producing a 2-azaadamantane represented by the formula (1), which comprises cyclizing a compound represented by the following formula (2) in the presence of an acid.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: March 11, 2014
    Assignees: Nissan Chemical Industries, Ltd., Tohoku Techno Arch Co., Ltd.
    Inventors: Toshimasa Hamada, Noriaki Nagahama, Masami Kozawa, Yoshiharu Iwabuchi, Masatoshi Shibuya, Masaki Tomizawa, Yusuke Sasano
  • Publication number: 20130172543
    Abstract: A method for oxidizing an alcohol, wherein oxidation is performed in the presence of a compound represented by the following formula (I) and a bulk oxidant, which enables efficient oxidation of secondary alcohols as well as primary alcohols, and can attain high reaction efficiency even when air is used as a bulk oxidant.
    Type: Application
    Filed: May 30, 2011
    Publication date: July 4, 2013
    Applicant: TOHOKU UNIVERSITY
    Inventors: Yoshiharu Iwabuchi, Masaki Hayashi
  • Publication number: 20130129832
    Abstract: A cognitive impairment ameliorant is provided that is useful for the prevention or treatment of cognitive impairment, and particularly Alzheimer's disease. The cognitive impairment ameliorant contains royal jelly as an active ingredient thereof.
    Type: Application
    Filed: January 15, 2013
    Publication date: May 23, 2013
    Applicants: TOHOKU UNIVERSITY, JAPAN ROYAL JELLEY CO., LTD.
    Inventors: Kikuji YAMAGUCHI, Yasushi OHIZUMI, Tohru YAMAKUNI, Akira NAKAJIMA, Yoshiharu IWABUCHI, Masatoshi SHIBUYA
  • Publication number: 20120310005
    Abstract: To provide a method whereby a 2-azaadamantane can easily be obtained in good yield. A method for producing a 2-azaadamantane represented by the formula (1), which comprises cyclizing a compound represented by the following formula (2) in the presence of an acid.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 6, 2012
    Applicants: TOHOKU TECHNO ARCH CO., LTD., Nissan Chemical Industries, Ltd.
    Inventors: Toshimasa HAMADA, Noriaki NAGAHAMA, Masami KOZAWA, Yoshiharu IWABUCHI, Masatoshi SHIBUYA, Masaki TOMIZAWA, Yusuke SASANO
  • Patent number: 8273889
    Abstract: The invention provides a method for producing 2-azaadamantanes represented by formula (1) in good yields. The method includes cyclizing a compound represented by formula (2) in the presence of an acid.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: September 25, 2012
    Assignees: Nissan Chemical Industries, Ltd., Tohoku Techno Arch Co., Ltd.
    Inventors: Toshimasa Hamada, Noriaki Nagahama, Masami Kozawa, Yoshiharu Iwabuchi, Masatoshi Shibuya, Masaki Tomizawa, Yusuke Sasano
  • Patent number: 8178727
    Abstract: It has been demanded to improve the poor solubility of curcumin to develop an anti-tumor compound capable of inhibiting the growth of various cancer cells at a low concentration. Thus, disclosed is a novel synthetic compound, a bis(arylmethylidene)acetone, which has both of an excellent anti-tumor activity and a chemo-preventive activity. A bis(arylmethylidene)acetone (i.e., a derivative having a curcumin skeleton) which is an anti-tumor compound and has a chemo-preventive activity is synthesized and screened. A derivative having enhanced anti-tumor activity and chemo-preventive activity can be synthesized.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: May 15, 2012
    Assignee: National University Corporation Tohoku University
    Inventors: Hiroyuki Shibata, Yoshiharu Iwabuchi, Hisatsugu Ohori, Hiroyuki Yamakoshi, Yuichi Kakudo
  • Publication number: 20110287106
    Abstract: A cognitive impairment ameliorant is provided that is useful for the prevention or treatment of cognitive impairment, and particularly Alzheimer's disease. The cognitive impairment ameliorant contains royal jelly as an active ingredient thereof.
    Type: Application
    Filed: June 16, 2009
    Publication date: November 24, 2011
    Inventors: Kikuji Yamaguchi, Yasushi Ohizumi, Tohru Yamakuni, Akira Nakajima, Yoshiharu Iwabuchi, Masatoshi Shibuya
  • Publication number: 20100311977
    Abstract: To provide a method whereby a 2-azaadamantane can easily be obtained in good yield. A method for producing a 2-azaadamantane represented by the formula (1), which comprises cyclizing a compound represented by the following formula (2) in the presence of an acid.
    Type: Application
    Filed: November 20, 2008
    Publication date: December 9, 2010
    Applicants: Nissan Chemical Industries, Ltd., Tohoku Techno Arch Co., Ltd.
    Inventors: Toshimasa Hamada, Noriaki Nagahama, Masami Kozawa, Yoshiharu Iwabuchi, Masatoshi Shibuya, Masaki Tomizawa, Yusuke Sasano
  • Publication number: 20100152493
    Abstract: It has been demanded to improve the poor solubility of curcumin to develop an anti-tumor compound capable of inhibiting the growth of various cancer cells at a low concentration. Thus, disclosed is a novel synthetic compound, a bis(arylmethylidene)acetone, which has both of an excellent anti-tumor activity and a chemo-preventive activity. A bis(arylmethylidene)acetone (i.e., a derivative having a curcumin skeleton) which is an anti-tumor compound and has a chemo-preventive activity is synthesized and screened. A derivative having enhanced anti-tumor activity and chemo-preventive activity can be synthesized.
    Type: Application
    Filed: June 27, 2006
    Publication date: June 17, 2010
    Inventors: Hiroyuki Shibata, Yoshiharu Iwabuchi, Hisatsugu Ohori, Hiroyuki Yamakoshi, Yuichi Kakudo
  • Patent number: 7705152
    Abstract: An alcohol oxidation catalyst which is an organic oxidation catalyst to oxidize an alcohol, which contains azabicyclo[3.3.1]nonane N-oxyl represented by the following formula (1) having an N-oxyl group incorporated in a bicycle[3.3.1]nonane skeleton: wherein X is H2, O or NOH.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: April 27, 2010
    Assignee: Nissan Chemical Industries, Ltd.
    Inventors: Yoshiharu Iwabuchi, Masatoshi Shibuya, Masaki Tomizawa